| Name | immunoglobulin (protein family or complex) |
|---|---|
| Synonyms | Immunoglobulin; Immunoglobulins |
| Name | MAA |
|---|---|
| CAS | methylarsonic acid |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 11023194 | Fujii S, Huang S, Fong TC, Ando D, Burrows F, Jolly DJ, Nemunaitis J, Hoon DS: Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients. Cancer Gene Ther. 2000 Sep;7(9):1220-30. Patients were assessed for immunoglobulin G antibody (Ab) responses to the melanoma-associated antigens (MAA) tyrosinase, gp100, TRP-2, and MAGE-A1 by affinity enzyme-linked immunosorbent assay. |
1(0,0,0,1) | Details |
| 6224998 | Obukhov NV, Ametov AS, Abedrabbo Kh: [Radionuclide complex in vitro studies in the diagnosis of lung cancer] . Med Radiol. 1983 Aug;28(8):19-24. The concentration in the blood serum of biologically active agents: CEA, PTH, immunoglobulin E, ferritin, and beta2-microglobulin was determined in 76 cancer patients and 19 patients with nontumorous lung diseases. |
1(0,0,0,1) | Details |
| 1373670 | Temponi M, Gold AM, Ferrone S: Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen. Cancer Res. 1992 May 1;52(9):2497-503. |
1(0,0,0,1) | Details |
| 19134253 | Qiao XH, Xie XT, Jiang SY, Shi W, Li W, Zhou JJ: [Natural history of moderate aplastic anemia in children and effects of immunosuppressive therapy]. Zhonghua Er Ke Za Zhi. 2008 Dec;46(12):909-13. At the second stage, the patients with MAA progressed to SAA were given combined immunosuppressive (CIS) therapy (CIS group, a combination of ATG, CSA and high-dose immunoglobulin). |
1(0,0,0,1) | Details |
| 16061683 | Wang X, Ko EC, Peng L, Gillies SD, Ferrone S: Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2. Cancer Res. 2005 Aug 1;65(15):6976-83. Conjugation of human interleukin 2 (IL-2) to mAb MK2-23 variable regions covalently linked to human immunoglobulin constant regions enhanced mAb MK2-23 immunogenicity in BALB/c mice to an extent similar to that induced by mAb MK2-23 conjugated to KLH and given with Freund's adjuvant. |
1(0,0,0,1) | Details |
| 4005860 | Buraggi GL, Callegaro L, Mariani G, Turrin A, Cascinelli N, Attili A, Bombardieri E, Terno G, Plassio G, Dovis M, et al.: Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F (ab') 2 fragments. Cancer Res. 1985 Jul;45(7):3378-87. |
4(0,0,0,4) | Details |
| 9430197 | Mutz M, Hawthorne T, Ferrone S, Pluschke G: Titration calorimetry study of an anti-idiotypic antibody cascade in a human melanoma-associated antigen system. Mol Immunol. 1997 Jul;34(10):695-707. The values of the binding enthalpy showed only small variations when binding of the idiotypic mAb CGP 76873 to four variants of the anti-idiotypic mAb CGP 60686 with different immunoglobulin constant regions, but identical variable regions were compared. |
2(0,0,0,2) | Details |
| 17033770 | Hua XF, Liu TC, Cao YC, Liu B, Wang HQ, Wang JH, Huang ZL, Zhao YD: Characterization of the coupling of quantum dots and immunoglobulin antibodies. Anal Bioanal Chem. 2006 Nov;386(6):1665-71. Epub 2006 Oct 11. |
2(0,0,0,2) | Details |
| 9060545 | Du Bois JS, Trehu EG, Mier JW, Shapiro L, Epstein M, Klempner M, Dinarello C, Kappler K, Ronayne L, Rand W, Atkins MB: Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma. J Clin Oncol. 1997 Mar;15(3):1052-62. |
2(0,0,0,2) | Details |
| 19269415 | Liu J, Zhao W, Fan RL, Wang WH, Tian ZQ, Peng J, Pang DW, Zhang ZL: Investigation of the nonspecific interaction between quantum dots and immunoglobulin G using Rayleigh light scattering. Talanta. 2009 May 15;78(3):700-4. Epub 2008 Dec 24. |
2(0,0,0,2) | Details |
| 2576398 | Boyages SC, Bloot AM, Maberly GF, Eastman CJ, Li M, Qian QD, Liu DR, van der Gaag RD, Drexhage HA: Thyroid autoimmunity in endemic goitre caused by excessive intake. Clin Endocrinol. 1989 Oct;31(4):453-65. Serum was tested for antimicrosomal (MAb), anti-thyroglobulin (TgAb), second colloid antigen antibodies (CA2-Ab) and TSH binding inhibitory immunoglobulins (TBII). |
2(0,0,0,2) | Details |
| 12612978 | Linossier MT, Palle S, Berthoux F: Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin. Am J Kidney Dis. 2003 Mar;41(3):558-64. BACKGROUND: Abnormal glycosylation of immunoglobulin A1 (IgA1) has been implicated in the pathophysiological characteristics of IgA nephropathy, leading to failure of normal clearance mechanisms and mesangial deposition of serum IgA1. |
1(0,0,0,1) | Details |
| 10733543 | Rolla R, Vay D, Mottaran E, Parodi M, Traverso N, Arico S, Sartori M, Bellomo G, Klassen LW, Thiele GM, Tuma DJ, Albano E: Detection of circulating antibodies against malondialdehyde- adducts in patients with -induced liver disease. Hepatology. 2000 Apr;31(4):878-84. Immunoglobulin G (IgG) reacting with MAA-modified proteins were significantly increased in the patients with -induced cirrhosis or hepatitis. |
1(0,0,0,1) | Details |
| 1934623 | Norton FL, Shuey SR, Kohler H: Response of huSCID mice reconstituted with lymphocytes from anti-idiotype-treated melanoma patients. Clin Immunol Immunopathol. 1991 Dec;61(3):332-42. All of the huSCID mice reconstituted fully as evidenced by their production of human immunoglobulins. |
1(0,0,0,1) | Details |
| 18623333 | Kondo A, Teshima T: Preparation of immobilized enzyme with high activity using affinity tag based on proteins A and G. Biotechnol Bioeng. 1995 Jun 5;46(5):421-8. Affinity tag AG consisting of immunoglobulin G (lgG)-binding domains of protein A from Staphylococcus aureus (EDABC) and those of protein G from Streptococcus strain G148 (C2C3) were used to facilitate immobilization of beta-galactosidase (betagal) from Escherichia coli. |
1(0,0,0,1) | Details |
| 19156314 | Chen YW, Rick J, Chou TC: A systematic approach to forming micro-contact imprints of kinase. Org Biomol Chem. 2009 Feb 7;7(3):488-94. Epub 2008 Dec 15. Re-binding the molecularly imprinted polymers (MIPs) with non-template proteins, namely myoglobin, human serum albumin (HSA) and immunoglobulin G (Ig G), showed these proteins to have comparatively little affinity for the CK imprinted films. |
1(0,0,0,1) | Details |
| 11831396 | Kinuya K, Kakuda K, Matano S, Sato S, Sugimoto T, Asakura H, Kinuya S, Michigishi T, Tonami N: Prevalence of deep venous thrombosis in the lower limbs and the pelvis and pulmonary embolism in patients with positive antiphospholipid antibodies. Ann Nucl Med. 2001 Dec;15(6):495-7. BACKGROUND: Antiphospholipid antibodies (AA) are immunoglobulins that cross-react with phospholipid on cell membrane, and are therefore associated with a hypercoagulable state manifested by arterial/venous thromboses. |
1(0,0,0,1) | Details |